Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Clinical trial NCT01126190 · COMPLETED

Trial details

NCT number: NCT01126190
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia

Start date: 2010-06-30
Primary completion: 2012-02-29
Enrollment: 381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.